The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Skudexa 75 mg/25 mg film-coated tablets

75 mg/25 milligram(s) Film-coated tablet

Menarini International Operations Luxembourg S.A.PA0865/020/001

Main Information

Trade NameSkudexa 75 mg/25 mg film-coated tablets
Active SubstancesDexketoprofen
Tramadol hydrochloride
Strength75 mg/25 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberPA0865/020/001

Group Information

ATC CodeN02AJ Opioids in combination with non-opioid analgesics
N02AJ14 tramadol and dexketoprofen


Licence Issued26/02/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0103-161-058
Interchangeable List DocumentPDF of Interchangeable List
« Back